should i start with semaglutide or tirzepatide vs Tirzepatide: Head-to-Head for Weight Loss & Diabetes Tirzepatide vs. Semaglutide: What's the

Currently, 70% of the GLP-1 market is in the US and partially the EU, with a staggering 300% growth from 2020 to 2023 in prescriptions within the US alone

Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDAs Center for Drug Evaluation and Research, said in a statement

This mechanism of action has proven effective in promoting weight loss, as demonstrated by clinical trials and real-world use since its approval

Do not purchase if seal is broken

PlexusDx helps identify your genetic profile to optimize your individual timeline

Preparing for your Phoenix peptide therapy journey Maximize your results by preparing appropriately before beginning peptide therapy